Zanubrutinib
Obinutuzumab
Acalabrutinib
Update Venetoclax in CLL
ASH: COVID-19 Resources for Managing Blood Cancers
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL
Cancer.gov